Add like
Add dislike
Add to saved papers

Effect of three-dimensional reconstruction-assisted 23G micro-invasive vitrectomy in patients with proliferative diabetic retinopathy.

In the present study, we investigated the effect of optical coherence tomography (OCT) three-dimensional reconstruction-assisted 23G micro-invasive vitrectomy (abbreviated to'23G') in patients with proliferative diabetic retinopathy (PDR). A total of 66 PDR patients (66 eyes) were continuously selected and randomly divided into the control and observation groups with 33 patients in each group. Patients in the control group were treated with routine OCT examination while the patients in the observation group were treated with OCT three-dimensional retinal reconstruction. The 23G surgical method was applied to the two groups, and a comparison was made on the clinical effects in the two groups. The follow-up visits lasted for approximately 6 months, and it was found that the operative time, occurrence rate of intraoperative complications and postoperative complications as shown in the observation group were significantly less than those in the control group (P<0.05). The best corrected visual acuity (BCVA) was improved, the intraocular pressure was increased and retinal thickness was decreased after the treatment. The BCVA of patients in the observation group was significantly greater than that of patients in the control group while the intraocular pressure and retinal thickness of patients in the observation group were significantly less than those of patients in the control group (P<0.05). In conclusion, the effect of 23G surgical method in PDR patients can be improved and corresponding complications can be reduced under the assistance of OCT three-dimensional reconstruction.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app